microRNA in cellular senescence by Sedia, Carla
  
UNIVERSITA’ DI NAPOLI FEDERICO II 
 
 
DOTTORATO DI RICERCA IN BIOCHIMICA 
E BIOLOGIA MOLECOLARE E CELLULARE 
XXIII CICLO 
 
 
 
microRNA in cellular senescence 
 
 
 
 
 
 
 
 
Candidate:Dott.ssa Carla SEDIA 
      Tutor: Prof.ssa Raffaella FARAONIO 
.  
  
 
UNIVERSITA’ DI NAPOLI "FEDERICO II" 
 
 
 
DOTTORATO DI RICERCA 
BIOCHIMICA E BIOLOGIA MOLECOLARE E CELLULARE 
XXIII CICLO 
 
 
 
microRNA in cellular senescence 
 
 
 
Candidate 
 Carla Sedia 
 
 
 
 
 
Tutor            Coordinator 
Prof. Raffaella Faraonio            Prof. Paolo Arcari 
 
 
 
 
Academic Year 2010/2011 
 RINGRAZIAMENTI E DEDICHE 
 
I would like to thank Prof. Filiberto Cimino for giving me the opportunity 
to join his group; 
I thank prof.ssa Raffaella Faraonio for her tutorship in these years. 
I wish to thank dott.ssa Fabiana Passaro for her great enthusiasm and for 
enlightening scientific discussions. 
A special thank goes to prof. Massimo Santoro and his group at the 
Dipartimento di Patologia e Biologia Cellulare e Molecolare. I profited a 
lot from discussions with the members of his group; in particular I wish to 
thank dott. Paolo Salerno. 
I also want to thank the colleagues that work in the Dipartimento di 
Biochimica e Biotecnologie Mediche for their sustaining, friendship and 
instructive scientific discussions and in particular Camilla and Maria 
Luigia who has been a friend more than a colleague and support in times 
of difficulty and an ally in times of joy. 
I am especially grateful to my mother AnnaMaria, that has supported my 
dreams and aspirations giving me the privilege of the study, my father 
Luigi for having faith in me and for giving me the tough and durable 
character that has allowed me to overcome many obstacles, my brother 
Sergio and his family, in particular Michelle and Karen for having 
delighted these tree years with their birth. 
I would like to thank Madonna’s tribe for having welcomed me as a 
member of their family and for the serenity and joy that they infuse in me. 
Finally, these three years of doctoral study have made a gift to me. 
Thanks to Gabriele: his smile is my smile (thanks for the technical 
support with pc, too). 
He has taught me how to compose a puzzle: arrange the pieces one at a 
time, very patiently. The pieces of a puzzle, the pieces of an experiment, 
the pieces of my life.  
 
 
 
 
 
“We refuse to be  
What you wanted us to be;  
We are what we are:  
That's the way it's going to be. You don't know” 
  
  
 
 
 
 
 
 
 
Ai miei due sborbottoni 
 
 
 SUMMARY 
 
Senescence is recognized as a permanent arrest of cell proliferation 
triggered by telomere shortening or various stresses. Senescence imposes 
a barrier to tumorigenesis and contributes to aging. It represents a cell 
response that encompasses gene expression regulation at transcriptional 
and post-transcriptional levels. MicroRNAs (miRNAs or miRs) are small 
non-coding RNAs that regulate diverse biological processes through their 
control of mRNA degradation or translation. 
In this work, we have analyzed the expression profiles of 284 known 
microRNAs in senescent relative to early-passage IMR90 human diploid 
fibroblasts. We found that 179 microRNAs were expressed at significant 
level and that in senescent cells 47% were downregulated (at least 2-fold) 
and 19% were upregulated at same extent.  
With only few exceptions, a similar expression profile was observed in 
human senescent BJ fibroblasts, as well as in young IMR90 fibroblasts 
treated with a mild chronic oxidative stress or with etoposide. The 
upregulated microRNAs, validated by Quantitative Real Time PCR, 
included miR-23b, miR-30e-5p, miR-126*, miR-134, miR-200c, miR-
210, miR-376a*, miR-369-5p, miR-379, miR-410, miR-432, miR-485-5p, 
miR-486, miR-494, miR-542-5p, miR-654, miR-656 and some of them 
(miR-134, miR-369-3p, miR-376a*, miR-379, miR-410, miR-432, miR-
485-5p, miR-494, miR-654 and miR-656) are members of an imprinted 
region of human chromosome 14.  
We found that ectopic expression of some of the upregulated microRNAs 
(miR-210, miR-376a*, miR-486, miR-494, miR-542-5p, miR-654) in 
young proliferating fibroblasts triggers a premature senescent phenotype 
showing typical markers of senescence and accompanied also by the 
appearance of molecular complexes involved in different patterns of DDR 
(DNA damage response). 
 
 
 RIASSUNTO 
 
La senescenza cellulare viene riconosciuta come un arresto permanente 
della proliferazione cellulare dovuto all‟accorciamento dei telomeri o 
anche ad altri tipi di stress. La senescenza cellulare è considerata un 
meccanismo di soppressione tumorale e contribuisce all‟invecchiamento 
dell‟organismo. Rappresenta, altresì, una risposta cellulare che coinvolge 
la regolazione dell‟espressione genica a livello trascrizionale e post-
trascrizionale. I microRNA (miRNA o miR) sono una classe di piccoli 
RNA non codificanti che regolano diversi processi biologici attraverso il 
controllo della traduzione o degradazione dell‟mRNA target. 
In questo lavoro abbiamo confrontato il profilo di espressione di 284 
microRNA umani noti in cellule IMR90 senescenti in seguito a ripetute 
duplicazioni in vitro rispetto a cellule giovani. Abbiamo così trovato che 
179 microRNA sono espressi in questa linea cellulare a livelli 
significativi e che il 47% di essi è presente a livelli più bassi in cellule 
senescenti rispetto a quelle giovani mentre il 19% risulta presente a livelli 
più alti (almeno di due volte). 
Un profilo di espressione pressoché identico, con poche eccezioni, è stato 
riscontrato in cellule BJ senescenti cosi come in IMR90 giovani trattate 
con stress ossidativo cronico moderato o con Etoposide. I microRNA 
iper-espressi risultanti dallo screening e dalle successive validazioni con 
PCR Real Time quantitativa sono: miR-23b, miR-30e-5p, miR-126*, 
miR-134, miR-200c, miR-210, miR-376a*, miR-369-5p, miR-379, miR-
410, miR-432, miR-485-5p, miR-486, miR-494, miR-542-5p, miR-654, 
miR-656 e alcuni di essi (miR-134, miR-369-3p, miR-376a*, miR-379, 
miR-410, miR-432, miR-485-5p, miR-494, miR-654 e miR-656) 
appartengono ad un‟unica regione cromosomica localizzata sul 
cromosoma 14 umano. 
Noi abbiamo trovato che l‟espressione ectopica di alcuni microRNA 
risultati iper-espressi in senescenza (miR-210, miR-376a*, miR-486, 
miR-494, miR-542-5p, miR-654) in cellule IMR90 giovani induce la 
comparsa di un fenotipo senescente prematuro che mostra i tipici 
marcatori della senescenza accompagnato anche dalla comparsa di alcuni 
complessi molecolari associati al DDR (DNA damage response).  
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1. INTRODUCTION 
 
1.1 Cellular senescence 
Cellular senescence is an irreversible arrest of cell proliferation that 
occurs in somatic cells within multicellular organisms and is caused by 
loss of replicative potential. Senescent cells are metabolically active but 
because they lack the capacity to replicate, are unable to perform DNA 
synthesis and continue to grow (1). 
Therefore cellular senescence has been considered as a model of 
mammalian aging. The term “cellular senescence” was used for the first 
time in 1960s by Hayflick and Moorhead to describe the inevitable and 
irreversible proliferation arrest of primary human cells in culture, a 
phenomenon known as the “Hayflick limit”(2). They reported the 
inability of normal human diploid cells to undergo further replication in 
spite of physiological mitogenic stimuli after a finite numbers of 
divisions; this type of senescence was defined replicative senescence. 
Before then, it was believed that cellular senescence was an artefact due 
to culture conditions, until a series of findings demonstrated that aging of 
cells is an intrinsic phenomenon, specific for each cell type in vitro and 
in vivo. Hayflick and Moorhead worked with fibroblasts, a cell type 
found in connective tissues, but replicative senescence has been found in 
other cell types: keratinocytes, endothelial cells, lymphocytes, 
adrenocortical cells, vascular smooth muscle cells, chondrocytes, but 
with different characteristics. The replicative senescence described by 
Hayflick and colleagues results, at least in part, from telomere 
shortening. In normal human fibroblast cells, telomeres become 
progressively shorter with each population doubling until they reach a 
critically short length. Critically short telomeres are only one of signals 
that can induce permanent growth arrest in primary cell types (3). This 
cell fate program indeed occurs in response also to environmental 
stresses, mainly oxidative stress (SIPS: stress-induced premature 
senescence) (4), and activated oncogenes (OIS: oncogene-induced 
senescence) (5). Compelling evidences obtained in recent years 
demonstrate that DNA damage is a common mediator for both replicative 
senescence triggered by telomere shortening and premature senescence 
induced by oncogenic stress, oxidative stress and others stressors. 
A key concept is that senescent cells have common evident features 
despite the multiple cellular types involved. These features are termed 
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"biomarkers" (Figure 1) (6). The most obvious biomarker is the growth 
arrest, which can be detected by analysis of levels of cell-cycle related  
 
 
 
 
 
Figure 1: Causes of senescence and main features of senescent cells. 
The major cause of senescence is critically short telomeres but this is only one of signals that can 
induce permanent growth arrest in primary cell types. This cell fate program occurs in response also 
to environmental stresses, mainly oxidative stress, activated oncogenes, DNA damage and other 
stimuli.  
All forms of cellular senescence share common features: growth arrest, morphological changes, 
decreased synthesis of DNA, modification of gene expression profiles, altered response to 
apoptosis, increased -galactosidase activity and alteration of chromatin structure with appearance 
of specific foci called senescence-associated heterochromatic foci (SAHFs).  
 
 
 3 
 
proteins and DNA synthesis. In fact, various cell growth-regulatory 
proteins, including p21
WAF1
, p16
INK4a
 are up-regulated with senescence 
and exhibit altered activation states. Another important biomarker is the 
cellular morphology. The progressive morphological changes were 
particularly well-studied by Klaus Bayreuther and colleagues (7). In 
brief, senescent cells become flattened, enlarged, granular and lacking 
vacuoles. Furthermore, senescent population has more diverse 
morphologies than young cells. In fact, a confluent senescent culture has 
a smaller cellular density than a confluent one, though this also occurs 
because senescent cells are more sensitive to cell-cell contact inhibition. 
In 1995, Judith Campisi and her team discovered that the enzyme β-
galactosidase, a lysosomal hydrolase, has an abnormal behavior in 
senescent cells. This activity was termed senescence-associated β-
galactosidase (SA-β-galactosidase). While the significance of this change 
is still not clear, it appears to result from rather profound changes in the 
lysosomal compartment of senescent cells. This lysosomal enzyme is 
normally active at pH 4, but its quantity increases to a level that can be 
detected at suboptimal pHs, such as 6.0 (8). Both in vitro and in vivo, the 
percentage of positive cells for SA-β-galactosidase increases with, 
respectively, population doubling level (PDL) and age (9). In many cell 
types, such as human fibroblasts, senescence arrest is accompanied by 
formation of distinct structures, referred to as senescence-associated 
heterocromatic foci (SAHF), that accumulate in the cellular nuclei and 
silence proliferation-promoting genes, such as cyclin A. SAHF positive 
cells have been shown to occur with the same kinetics as other markers 
of senescence (SA-β-galactosidase, p21WAF1 and p16INK4a over-
expression). Moreover, during senescence, SAHFs strongly correlate 
with the irreversibility of the senescent phenotype and might be the 
mechanism that defines the point of no return in terms of growth arrest 
(10). As mentioned before, DNA damage is a common mediator of the 
onset of cellular senescence. The relevance of DNA damage response 
(DDR) in the induction of permanent growth arrest is highlighted by the 
observation that hallmarks of DDR, known as senescence-associated 
DNA-damage foci (SDFs) can be identified in aging mammalian tissues. 
Also senescent human fibroblasts display molecular markers 
characteristic of cells bearing DNA double-strand breaks. These markers 
include nuclear foci of phosphorylated histone H2AX and their co-
localization with DNA repair and DNA damage checkpoint factors such 
as 53BP1, MDC1 and NBS1 (see after). 
Senescent cells show striking changes in gene expression. Various 
growth–regulatory genes exhibit altered expression; in fact they are 
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upregulated in senescence and are involved in cell-cycle arrest. Senescent 
cells also repress genes that encode proteins that stimulate or facilitate 
cell-cycle progression. Interestingly, many changes in gene expression 
appear to be unrelated to the growth arrest. Many senescent cells 
overexpress genes that encode secreted proteins. In fact, senescent cells 
also display the capacity to communicate with their environment by 
secreting a myriad of factors. This “senescence associated secretory 
phenotype (SASP), also known as “senescence messaging secretome” 
(SMS), includes a wide range of growth factors, proteases, chemokines 
and cytokines of the proinflammatory networks, such as IL-6 and IL-8, 
which could have many paracrine effects on the extracellular 
environment (11).  
Like senescence, apoptosis is an extreme response to cellular stress and is 
an important tumor-suppressive mechanism. But, whereas senescence 
prevents the growth of damaged or stressed cells, apoptosis quickly 
eliminates them. Many (but not all) cell types acquire resistance to 
certain apoptotic signals when they become senescent and this 
phenomenon might partly explain why senescent cells are so stable in 
culture (12). It is not clear what determines whether cells undergo 
senescence or apoptosis. One determinant is cell type; for example, 
damaged fibroblasts and epithelial cells tend to senesce, whereas 
damaged lymphocytes tend to undergo apoptosis. The nature and 
intensity of the damage or stress may also be important (13). Moreover, 
manipulation of pro- and anti-apoptotic proteins can cause cells that are 
destined to die by apoptosis to senesce and, conversely, cause cells that 
are destined to senesce to undergo apoptosis (14). The senescence and 
apoptosis regulatory systems therefore communicate probably through 
their common regulator, the p53 tumor suppressor protein (15). The 
mechanisms by which senescent cells resist apoptosis are poorly 
understood. In some cells, resistance might be due to expression changes 
in proteins that inhibit, promote or implement apoptotic cell death. In 
others, p53 might preferentially transactivate genes that arrest 
proliferation, rather than those that facilitate apoptosis (16). Other results 
also suggest that during in vitro aging increased autophagy. Autophagy is 
a genetically regulated program responsible for the turnover of cellular 
proteins and damaged or superfluous organelles. Autophagy is often 
associated with acute metabolic changes and rapid protein replacement. It 
is identified that autophagy as a new effector mechanism of senescence, 
important for the rapid protein remodeling required to make the efficient 
transition from a proliferative to a senescent state (17). Cellular 
senescence is thought to have evolved as a mechanism to prevent 
 5 
 
damaged DNA being passed on to future generations of cells and for this 
reason it can be considered a tumor suppressor mechanism. In fact, a 
series of studies have reported that senescent cells are abundant within 
pre-malignant neoplastic lesions, but scarce in malignant tumors (18). 
Numerous evidences support the hypothesis that cellular senescence in 
vivo exerts a critical role in organism aging and aging-associated 
degenerative diseases. It is now widely accepted that the progressive 
accumulation of senescent cells with age, leads to decline in tissue 
homeostasis, most likely through stem cell depletion and/or tissue 
structure impairment/disruption (19). At the same time, the persistence of 
senescent cells entails an increased expression of SASP factors that 
contribute to chronic inflammation which drives aging and most age-
related diseases (19). Thus, senescence can be considered a double-edged 
sword: on one hand can be viewed as a mechanism of defence to 
neoplastic transformation; on the other hand, with the abnormal paracrine 
signalling, could contribute, in vivo, to the general and progressive 
deterioration recognized as in vivo aging, thereby promoting age-related 
diseases (20).  
 
1.2 Molecular mechanisms of cellular senescence. 
 
Detailed investigations at the molecular level have revealed two major 
tumor suppressor pathways for the induction of cellular senescence: 
p53/p21
WAF1
 and p16
INK4a
/Rb (Figure 2). Replicative senescence is 
telomere-dependent and is mediated by the p53- p21
WAF1
 pathway (20) 
and also encompasses the DNA-damage response (DDR) mechanism. In 
contrast, a telomere-independent mechanism of senescence, typically 
activated by oxidative stress, is mediated by the p16
INK4a
 pathway (21, 
22). Both of these pathways converge on retinoblastoma protein (Rb), 
which is responsible for allowing progression from G1 to S phase. 
1.2.1 p53 pathway  
A linear sequence of events has been elucidated involving the 
transcriptional activator and tumor-suppressor protein, p53; the cyclin-
dependent kinase inhibitor, p21
WAF1
 and the cell-cycle regulator, Rb, as 
the principal players in telomere-dependent senescence.  
p53 has been named the “guardian of the genome” and is mutated in 50% 
of all tumors. It acts as an integrator for various signal stresses and can 
mediate cell cycle arrest, DNA repair, apoptosis, senescence and 
differentiation. The type of response is affected by cell type, oncogenic 
status, intensity of stress and p53 expression level. The sensing of DNA 
damage, including telomere shortening, and activation of p53 in G1  
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Figure 2: Signaling pathways leading to cellular senescence. 
The onset of cellular senescence is regulated by two tumor-suppressor pathways, p53-p21
WAF1
-Rb 
and p16
INK4a 
–Rb. Telomere shortening induces senescence mainly through the DNA damage 
pathway, activating the ATM/ATR pathway and CHK1/CHK2 to stabilize p53. In human cells 
p16
INK4a
 is activated in certain settings in response to telomere shortening, through unknown 
pathways. Direct DNA damage activates the senescence program mainly through p53, in essentially 
the same manner as telomere shortening.  
Oxidative stress induces DNA damage, and also accelerates telomere shortening, possibly leading 
to accelerated telomere uncapping. The downstream response is mediated through the DNA 
damage pathway and through activation of p16
INK4a
, and may be mediated through p38MAPkinase. 
RAS oncogene activation induces senescence mainly through p16
INK4a
 in human cells. 
p38MAPkinase plays a role in mediating RAS-induced senescence. p16
INK4a
 is also activated by 
additional physiologic stresses, such as nutrient and growth factor deficiency. The exact stimuli for 
this activation and the pathways mediating it are unknown.  
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prevents abnormal DNA being replicated in S phase. The functions of 
cell-growth arrest and apoptosis are therefore critical roles of the p53 
protein: it limits the ability of damaged cells to pass on aberrant DNA or 
to develop neoplastic potential. Indeed, many human tumors possess 
mutated p53 protein that is deficient in activity (23, 24, 25), whereas 
suppression of p53 expression results in emergence of cells from 
senescence, resumption of replication and immortalization (26). Initial 
evidence for the transcriptional regulation of p53 during replicative 
senescence was provided by Kulju and Lehman (27), who found p53 
mRNA and p53 protein levels increased in senescent IMR-90 diploid 
fibroblast compared with young cells. They also noted an increase in 
phosphorylated p53 in cells nearing senescence. The mechanisms by 
which telomere-shortening or DNA-damage signals are transduced to the 
p53 protein remain to be fully elucidated. Double strand breaks (DSBs) 
are sensed by specialized complexes (MRN), formed by MRE11, Rad50, 
NBS1 that recruit and activate two large protein kinases, ataxia 
telangiectasia and Rad3-related (ATR) or ataxia-telangiectasia mutated 
(ATM), respectively, at the site of the DNA lesion. ATM undergoes 
auto-phosphorylation and activated ATM phosphorilates the histone 
variant H2AX. By a complex action of sensors, transducers and effectors, 
ATM and also ATR induce p53 phosphorylation (28). ATM and ATR 
translocate to sites of DNA damage where the histone H2AX is 
posphorylated to γ-H2AX (in fact this is used such as marker of 
senescence). γ-H2AX is thought to induce changes in the local chromatin 
structure, thus facilitating in the focal assembly of DNA-repair proteins 
and the checkpoint proteins CHK1 and CHK2. ATM and ATR are then 
able to phosphorylate CHK1 and CHK2, which subsequently activate 
p53 (29, 30, 31, 32). ATM can phosphorylate p53 directly or indirectly 
by phosphorylation of CHK2 at Thr68 (33), which in turn directly 
phosphorylates p53 (34, 35) (Figure 3). Because of the critical role that 
p53 has in controlling cellular activities, the mechanisms regulating p53 
are necessarily complex and consist of a range of post-translational 
changes to the protein. These include phosphorylation (36), acetylation 
(37) and redox control (38). Once activated, p53 initiates a series of 
downstream transcriptional events. An immediate target is the p21 gene 
(39), which encodes the potent cyclin-dependent kinase 2 (Cdk2) 
inhibitor, p21
WAF1
. In fact, p21
WAF1
 is overexpressed in senescent cells 
(39), that generally arrests cell-growth in G1 phase. The downstream 
target of p53, p21
WAF1
 can induce senescence in tumor cell lines 
independent of p53 status (40), and human diploid fibroblasts lacking 
p21
WAF1
 bypass senescence (41)
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This indicates an important role of p21
WAF1
 for induction of senescence 
in human cells. 
 
 
 
From D’Adda di Fagagna, Nature Review Cancer, 8: 512-522 (2008). 
 
Figure 3: The DNA -damage response (DDR).  
The DDR is robustly activated by double strand breaks (DSBs) and/or the exposure of single-
stranded DNA (ssDNA). DSBs are sensed by the MRE11–RAD50–NBS1 (MRN) complex and 
NBS1 recruits the apical protein kinase ATM. ATM undergoes autophosphorylation, and activated 
ATM phosphorylates the histone H2A variant H2AX at the site of DNA damage. γH2AX 
(phosphorylated H2AX) is recognized by a phospho-specific domain of MDC1, that fuels the 
additional accumulation of MRN (to which MDC1 binds), which leads to amplified local ATM activity 
and the spreading of γH2AX along the chromatin. This in turn causes a local increase of several 
DDR factors at the site of DNA damage, thereby generating a positive feedback loop that amplifies 
ATM activity.  
Single-stranded DNA is sensed by the protein RPA (replication protein A) that localized at sites of 
SSD. Once RPA-coated single-stranded DNA forms, the recruitment of the heterodimeric complex 
that comprises ATR (a paralogue of ATM) and its DNA-binding subunit ATRIP is favored.  
Not all DDR factors accumulate at sites of DNA damage. The protein kinase CHK2 is thought to 
transiently localize at sites of DNA damage only for enough time to be phosphorylated and activated 
by ATM. Similarly, although a fraction of CHK1 is chromatin bound in undamaged cells, ATR-
dependent phosphorylation of CHK1 allows it to freely diffuse in the nucleus. Therefore, both CHK1 
and CHK2 are responsible for DDR signalling in nuclear regions distant from the DNA-damage site. 
Finally, p53 induces cell-cycle arrest by activating the transcription of p21
WAF1
, a CDK inhibitor that 
blocks cell-cycle progression.  
 
 9 
 
Rb is a cell-cycle regulator, one function of which is to control 
progression from G0 and G1 to S phase (42). Cell-cycle progression is 
dependent on hyperphosphorylation of Rb by cyclin-dependent kinases in 
association with cyclins to allow transcription of proliferative genes. Rb 
is regulated by Cdk2, Cdk4, and Cdk6 phosphorylation. p21
WAF1
 and 
p16
INK4a
 are Cdk inhibitors thereby leading to Rb hypophosphorylated. 
Hypophosphorylation of Rb inactivates the E2F transcription factor 
required for progression through S phase (43). The level of 
phosphorylation of Rb is fundamental to the correct regulation of its 
activities: the hyperphosphorylated form (active) predominates in 
proliferating cells, while hypophosphorylated (inactive) predominates in 
senescent cells (44). 
1.2.2 The p16INK4a pathway  
p16
INK4a 
is a critical regulator of cellular senescence acting through Rb 
but independent of p53 (Figure 2). Many senescence triggers have been 
shown to upregulate p16
INK4a
, including activated oncogenes, DNA 
damage, ROS, oxidative stress, dysfunctional telomeres and other poorly 
defined cell stresses (45). However, p16
INK4a
 is not as acutely or 
specifically responsive to DNA damage and dysfunctional telomeres as is 
the p53 target, p21
WAF1
. The expression of p16
INK4a
 is found to be 
increased in some senescent human fibroblasts, but several lines of 
evidence indicate that p16
INK4a
 induction is unlikely related to telomere 
shortening. The increased expression of p16
INK4a
 occurs after senescence 
has already been established in culture (46), in contrast to the rapid 
increase of p21
WAF1
 expression in cells approaching replicative 
senescence (47). Recent studies have revealed that a senescent population 
of human cells in culture is a mosaic of distinct subpopulations, some of 
which express p16
INK4a
, while others express p21
WAF1
 (48). p16
INK4a
 is 
responsive to more diverse stresses, through distinct regulatory pathways. 
Two of the best characterized of these are polycomb group complexes 
(PcGs) and stress-activated kinases p38MAPkinases. Several studies 
have implicated PcGs as direct regulators of the CDKN2a gene, which 
codes for p16
INK4a
 and alternative reading frame (ARF), an indirect 
activator of p53 (45). PcGs are collaborating multisubunit transcriptional 
repressor complexes that are direct repressors of p16
INK4a
 expression in 
proliferating cells, and their inactivation in senescent cells contributes to 
upregulation of p16
INK4a
. Several other studies have established that the 
stress-activated p38MAPkinases contribute to senescence-associated 
upregulation of p16
INK4a
 (49). Like p16
INK4a
, p38MAPkinase is activated 
by diverse stresses, including short telomeres, ROS and activated 
oncogenes. Between these triggers and activation of p38MAPkinase there 
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are various effectors, including MKK3/6 kinases in response to chronic 
RAS/ERK activation and the ROS activated MINK kinase.  
The mechanism by which p38MAPkinases activates p16
INK4a
 is not clear. 
Since one target of p38MAPkinase is the kinase MAPKAPK3, which has 
been reported to phosphorylate PcG proteins (50). It is possible that 
p38MAPkinase acts through PcGs. Phosphorylated PcGs dissociate from 
chromatin and derepress CDKN2A (50). In sum, p38MAPkinases and 
PcG proteins contribute to a stress-p38MAPkinase-PcG-p16
INK4a
 
pathway that is activated by diverse triggers of senescence 
 
1.3 Causes of senescence 
Most somatic cells have a finite number of divisions and eventually 
become senescent because of telomere shortening. In addition to 
replicative senescence, a senescent phenotype can be induced 
prematurely in early passage cells by several factors such as oxidative 
stress, overexpression of oncogenes, disruption of heterochromatin and in 
general by stressors that can elicit a DNA damage response. These forms 
of premature senescence are typically induced within several days and 
are not normally accompanied by telomere shortening. 
1.3.1 Telomere dysfunction  
The onset of replicative senescence is determined by the number of times 
that a cell population divides, suggesting that a mitotic clock records cell 
divisions (51, 52). It is now known that this clock is calibrated by 
telomere shortening in mammals (53, 54). Telomeres are guanine rich 
DNA regions composed of repetitive sequences (5‟-TTAGGG-3‟), that 
associate proteins to cap the ends of chromosomes. Telomeres have the 
critical function of protecting the end of linear chromosomes that short at 
each round of DNA replication. For each population doubling, telomeres 
tend to lose approximately 100 base pairs and when their length is 
drastically reduced the cells enter senescence assuring a finite number of 
replications. Experimental data suggest that the cellular life span can be 
measured by the progressive loss of telomere repeats and that silent genes 
adjacent to telomeres mediate senescence initiation (55). The critical 
length of telomeres is less than 5 kb and represents the threshold at which 
p53 and Rb pathways are activated and trigger senescence (56). The 
activity of the enzyme telomerase maintains the length of telomeres in 
germ cells and stem cells but not in most somatic cells in which this 
enzyme is not active. As a result, the length of telomeres gradually 
decreases during each replication. As mentioned before, the progressive 
shortening of telomeres is connected to the process of organismal aging 
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and to the activation of cellular senescence. By restoring and maintaining 
the telomere length, telomerase is believed to act as a “molecular clock” 
that functions to regulate the replication activity of cells and the onset of 
senescence (57). A strong telomerase activity has been detected in 
immortalized and tumor cells leading to the capacity to replicate 
infinitely and to a possible loss or inactivation of expression of specific 
genes involved in the senescence program and regulation of the normal 
cell cycle (58). The limited number of cell replications guaranteed by the 
gradual shortening of telomeres might protect the organism from the 
occurrence of cancer. Loss or dysfunction of telomeres indeed might lead 
to genomic instability and DNA damage. Therefore, the onset of 
senescence as a response to short dysfunctional telomeres represents a 
mechanism of tumor suppression in vivo that arrests division and growth 
of damaged cells at risk of malignant transformation (59). The 
mechanisms by which shortened telomeres are sensed and the senescence 
program is activated remain elusive. It has been proposed that telomere 
shortening acts as signal of DNA damage checkpoint pathway. The 
dysfunction detected in short telomeres activates a response similar to the 
one activated by DSBs (60) and activation of ordinarily silent 
„„senescence genes‟‟ located in SAHF (61).  
Recently, markers for DNA damage response, such as nuclear foci of 
phosphorylated histone H2AX, 53BP1, and MRE11 have been observed 
to localize at telomeres in senescent cells after serial passage (60), 
indicating that DNA damage response can be triggered by telomere 
shortening.  
1.3.2 Oxidative stress.  
Since Harman proposed the “free radical theory of aging”, oxidative 
stress is considered the major cause of cellular senescence and the aging 
of organism. According to this theory, the accumulation of oxidative 
damages produced by ROS at DNA, proteins and lipids results in loss of 
cellular homeostasis with accumulation of senescent cells and 
consequently aging (62). ROS are defined as compounds with high 
chemical reactivity due to an unpaired electron in the external orbital. 
The most important in biological functions are: superoxide anion (O2-• 
and nitric oxide (NO•. Other molecules, such as H2O2 (hydrogen 
peroxide) are not radicals itself but they easily produce, in the presence 
of iron, hydroxyl radical (•OH), particularly harmful and difficult to 
control (63, 64). In biological systems, ROS are constantly generated and 
eliminated. Cells, in fact, maintain an intracellular reducing environment 
and this redox state is insured by a normal intracellular balance between 
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ROS production, oxidant, and antioxidant defense systems (activities 
"scavengers" or "scavenger") of enzymatic nature, such as glutathione 
peroxidase complex and superoxide dismutase mitochondrial (SOD) and 
non-enzymatic compounds such as vitamins A, C, E, and polyphenols. 
The superoxide anion is neutralized by SOD enzyme that converts O2-• 
in H2O2. The cells therefore have developed a sophisticated system of 
defense against ROS. All work as scavengers of ROS, but can not 
directly intervene on biological macromolecules to remove the damage 
when it has already happened (65). Oxidative stress occurs when the 
amount of ROS overwhelms the reductive capacity of SOD and other 
protective systems. Harman's theory on ROS as a cause of aging has not 
yet been demonstrated in vivo, despite recent data obtained mainly in 
Caenorhabditis elegans, Drosophila and in mouse show a positive 
correlation between increased resistance to oxidative stress and 
elongation of life span (66, 67). On the contrary, the correlation between 
oxidative stress and senescence in vitro is well documented and 
numerous literature data have shown that natural oxidant compounds 
induce premature senescence. In fact, human fibroblasts undergo 
premature senescence when grown in high ambient oxygen conditions, 
40–50% oxygen. Conversely, the proliferative lifespan of these cells is 
extended when they are grown in low ambient oxygen, 2–3%, a condition 
more closely resembling physiologic oxygen levels (68, 69). Similarly, 
increase of intracellular ROS levels through hydrogen peroxide treatment 
or through the inhibition of ROS scavenging enzymes, such as 
superoxide dismutase SOD1, causes premature senescence (70). The 
activity of proteasome complex, that degrades oxidized proteins, has 
been observed to decline during senescence suggesting that oxidative 
stress induces accumulation of oxidative proteins that cannot be 
efficiently degraded. It has been suggested that oxidative stress, like 
telomere dysfunction, could acts through the p53→p21WAF1→Rb axis to 
induce senescence. Other studies indicate, however, that p16
INK4
 can be 
also activated in response to oxidative stress, possibly through the action 
of the p38MAPkinase protein (71).  
1.3.3 DNA-damage induced by drugs.  
The direct damaging of DNA achieved by treatment with DNA damaging 
agents, such as etoposide, cysplatin can induce cells to undergo 
senescence. Often though, the cellular response to several damages is cell 
death or reversible cell-cycle arrest, depending on the type of agent, the 
dosage administered and the type of cell treated (72). 
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Treatment of human fibroblasts with cytotoxic chemotherapic agents 
generally induces apoptosis or senescence in a dose-dependent manner. 
Treatment with low doses induces premature senescence whereas higher 
doses induce apoptosis. Etoposide in vitro reduces proliferation by 
inducing an irreversible arrest of cell cycle before mitosis, resulting in 
accumulation of cells in S and G2 phase of cell cycle. This effect is 
typical of drugs that interfere with DNA, affecting breaking one or both 
strands. It is known that the cytotoxic action of etoposide is dependent on 
its action on topoisomerase II. This enzyme plays a key role in the 
maintenance of physiological function allowing the breakage and repair 
of DNA during synthesis. In presence of etoposide, the enzyme forms a 
stable complex with DNA and this complex prevents the reunification 
with the rest of the DNA double helix. This event causes single and 
double-strand breaks, which inhibit DNA synthesis in the terminal phase. 
Treatment of human fibroblasts with low doses of etoposide (20 M) for 
a short period of time induces a DNA damage quickly highlighted and a 
massive induction of senescence after few days of treatment (73).  
1.3.4 Oncogene-induced senescence (OIS) 
Oncogene activation is a hallmark of cell transformation and cancer. 
However, oncogene activation in a normal cell does not lead to cell 
transformation, but instead induces cellular senescence (74). This 
paradox can be explained by considering the level of oncogene 
activation: low levels of oncogenes are involved in the onset of cancer 
while high levels are causative of the senescent phenotype. OIS is 
therefore a tumor suppressive mechanism that impedes the proliferation 
of a cell that expresses high levels of an aggressive oncogene. 
Importantly, this type of senescence is established independently of any 
telomere attrition or dysfunction (75). OIS was induced by several 
oncogenes, such as H-RAS
G12V
, BRAF
E600
, E2F1, MYC. It has recently 
been observed that cellular senescence, which is mediated by many 
different oncogenes and signalling factors, is associated with DDR 
activation (76, 77). Indeed, aberrant activation of signal transduction 
pathways and positive cell-cycle regulators can lead to the accumulation 
of DNA damage, full engagement of the DDR cascade and appearance of 
SDFs. Time-course studies have revealed that expression of the 
oncogenic form of HRAS leads to a biphasic response (78). RAS drives 
an initial hyperproliferation phase in which cells proliferate faster than 
control cells. However, this burst of proliferation is transient and is 
quickly followed by a proliferation slow down and the eventual 
establishment of cellular senescence (77). This biphasic response has also 
been observed following the expression of other oncogenes, such as 
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BRAF, E2F1 and MYC (77, 78, 79). DDR activation coincides in time 
with the end of hyperproliferation and entry into senescence. 
Interestingly, the engagement of the DDR pathways is subtly different in 
telomere attrition-induced and OIS. Telomere attrition mainly triggers 
ATM activation, with ATR engagement being detectable only in the 
absence of ATM. Conversely, ATR, have been detected in response to 
OIS (80).  
Although much remains to be learned about the mechanisms that lead to 
DNA-damage generation and DDR activation following oncogene 
activation, oncogene-induced DDR activation and senescence have been 
proposed to result from altered DNA replication. The best evidence that 
links an oncogene to DNA replication regulation is the recent discovery 
that MYC binds to DNA replication origins and activates the replication 
machinery. However, this is associated with the accumulation of DNA 
damage and activation of a DDR (79). Furthermore, oncogenic HRAS 
expression impacts on DNA replication and increases the number of 
simultaneously active DNA replication origins. This suggests that 
increased DNA-replication-origin usage caused by oncogenic depletes 
limiting DNA replication factors or generates regions of single-stranded 
DNA, which activate the ATR-dependent checkpoint (76). Thus, together 
with the observation that activated DDR markers localize at sites of 
ongoing DNA replication in oncogene-expressing cells, indicate that 
oncogene-induced DDR activation is a strictly DNA-replication-
dependent event. 
 
1.4 MicroRNAs 
The recent identification of microRNAs (miRNAs, miRs) has added a 
new layer of complexity to the regulation of gene expression. 
microRNAs are non-coding single-strand RNAs (ssRNAs) of ∼22 nt in 
length in their mature forms. They normally function as negative 
regulators of target mRNA expression at post-trascriptional level. 
microRNAs bind to the 3‟UTR of target mRNAs through base pairing, 
resulting in target mRNA cleavage or translation inhibition. It is believed 
that about 60% of human protein coding genes are regulated by 
microRNAs. Genes for microRNAs are an integral component of the cell 
genetic program, many of them also being evolutionarily conserved (81). 
The discovery of microRNAs was made in 1993, when Lee, Feinbaum, 
and Ambros discovered that lin-4, a gene of Caenorhabditis elegans did 
not code for a protein but instead produced a pair of short RNA 
transcripts that regulate the timing of larval development by translational 
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repression of lin-14, which encodes for a nuclear protein (82). They 
postulated that the regulation was due in part to sequence 
complementarity between lin-4 and unique repeats within the 3‟ UTR of 
the lin-14 mRNA. The downregulation of lin-14 at the end of the first 
larval stage initiates the developmental progression into the second larval 
stage. (83). It was 7 years later that the second microRNA, let-7, was 
discovered (84). Since the discovery of let-7, thousands of microRNAs 
have been identified in organisms as diverse as viruses, plants, worms, 
and primates through random cloning and sequencing or computational 
prediction (85, 86). The identified microRNAs are currently curated and 
annotated at miRBase, hosted by the Sanger Institute as an available 
repository.  
Studies on microRNA gene distribution throughout the genome have 
revealed their presence in clusters transcribed as polycistronic primary 
transcripts, or within regions transcribed as independent units, including 
intergenic regions, exon sequences of non-coding transcription units or 
intronic sequences of either protein coding or non-coding transcription 
units (87, 88). Intronic microRNAs orientated in the same direction of the 
surrounding genes are generally transcribed coincidentally with their host 
genes and excised by the splicing machinery from the larger transcript in 
which they are embedded (81). The biogenesis of microRNAs is 
illustrated by Figure 4.  
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From He et al., Nature Reviews Genetics, 5: 522 (2004) 
 
Figure 4: Biogenesis of microRNAs.  
microRNA genes are transcribed generally by RNA polymerase II (Pol II), generating the primary 
miRNA (pri-miRNA). In the nucleus, the RNase III endonuclease Drosha and the double-stranded 
RNA-binding domain (dsRBD) protein DGCR8/Pasha cleave the pri-miRNA to produce a 2-nt 3 
overhang containing the ∼70-nt precursor miRNA (pre-miRNA). Exportin-5 transports the pre-
miRNA into the cytoplasm, where it is cleaved by another RNase III endonuclease, Dicer, together 
with the dsRBD protein TRBP/Loquacious, releases the 2-nt 3 overhang containing a ∼21-nt 
miRNA:miRNA∗ duplex. The miRNA strand is loaded into an Argonaute-containing RNA-induced 
silencing complex (RISC), whereas the miRNA∗ strand is typically degraded. Once incorporated into 
RISC, the microRNA guides the complex to mRNA targets by base-pairing interactions. In cases of 
perfect or near-perfect complementarity to the microRNA, target mRNAs can be cleaved (sliced) 
and degraded; otherwise, their translation is repressed.  
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Transcription of microRNAs is typically performed by RNA polymerase 
II (Pol II). Primary transcripts, called pri-miRNAs, may be several 
kilobases long, bearing hairpin-shaped structures and transiently receive 
a 5′ cap and a poly(A) tail similar to that of the mRNAs. Recent studies, 
however, have shown that the RNA Pol III drives microRNA 
transcription from dense human clusters interspersed among repetitive 
Alu elements (89). 
The pri-miRNA is processed within the nucleus by a multiprotein 
complex called the Microprocessor, the core components of which are 
the RNase III enzyme Drosha and the double-stranded RNA-binding 
domain (dsRBD) protein DiGeorge syndrome chromosomal region 8 
(DGCR8/Pasha) (90, 91). This complex cleaves the pri-miRNA 
producing a 70-nt hairpin precursor microRNA (pre-miRNA). The 2-nt 
3‟ overhang, characteristic of RNase III–mediated cleavage, is 
recognized by Exportin-5, which transports the pre-miRNA into the 
cytoplasm via a Ran-GTP-dependent mechanism (92, 93). Next, the pre-
miRNA is cleaved to produce a mature 22-nt miRNA:miRNA* duplex 
by another RNase III enzyme, Dicer. This enzyme together with TRBP 
and Argonaute protein 2 (Ago2) forms a trimeric complex that initiates 
the assembly of the RNA-induced silencing complex (RISC), a 
ribonucleoprotein complex capable of binding dsRNA (94, 95). The 
microRNA strand with relatively lower stability of base-pairing at its 5‟ 
end is incorporated into RISC (miRISC complex), whereas the 
microRNA* strand is typically degraded (96). Once incorporated into 
RISC, the microRNA guides the complex to mRNA targets by base-
pairing interactions. In cases of perfect or near-perfect complementarity 
to the microRNA, target mRNAs can be cleaved (sliced) and degraded; 
otherwise, their translation is repressed (97, 98). Most animal 
microRNAs base-pair imperfectly with their targets and promote 
translational repression rather than cleavage and degradation. The 
mechanism of translational repression by microRNAs remains unclear. 
Indeed, the step at which microRNAs block translation is controversial. 
There is evidence that microRNAs block translation initiation, whereas 
other studies suggest a block in elongation (99, 100, 101, 102,). 
Therefore, the mechanisms proposed are three: 
1. miRISC mediates repression of translation because Ago2 itself 
competes with eiF4E for cap binding; 
2. miRISC stimulates deadenylation of the mRNA tail; 
3. miRISC block association of ribosomal subunits. 
Another important issue about microRNA-mediated regulation is the 
localization within cells of miRISC complex. Argonaute proteins and 
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microRNAs and their target mRNAs accumulate in processing bodies (P-
bodies), cytoplasmic foci that are known sites of mRNA degradation 
(102, 103). P-bodies exclude ribosomal components and may therefore 
serve as sites in which mRNAs can be stored without translation. Several 
proteins found in P-bodies can bind to Argonaute proteins, and this 
interaction mediates translational repression (104, 105). Yet, doubts 
remain over the importance of P-bodies in target repression. Disrupting 
P-bodies does not affect the degree of translational repression, and 
therefore the P-body localization may be a consequence of repression 
rather than its cause (106). Moreover, microRNA-mediated repression 
and P-body localization are reversible (107), indicating that the P-bodies 
may serve as sites of temporary storage of translationally repressed 
mRNAs. Due to multiple targets of each single microRNA, which are 
estimated several hundreds, they might resemble transcription factors that 
influence numerous cellular responses. In fact, microRNAs are involved 
as prominent regulators or fine-turnes in virtually all regulatory gene 
network, concerning development, cell proliferation, apoptosis and 
cancer. 
1.5 Biological role of microRNA in senescence 
In low organisms as Caenorhabditis elegans the microRNA lin-4 has 
been associated with life expectancy and mutations in gene greatly 
affects the lifespan of Caenorhabditis elegans (108). In more complex 
organisms a only few numbers of microRNAs have been linked to 
cellular senescence. Overwhelming evidences of the involvement of 
microRNAs in cellular senescence arise from the effect of Dicer‟s knock-
out, that resulted in premature senescence of mouse embryonic 
fibroblasts (MEFs). Ablation of Dicer, with the consequent loss of 
mature microRNAs, resulted in increased DNA damage, and p53 levels 
that lead to in inhibition of cell proliferation and premature senescence 
(109). This evidence indicates that alteration of microRNA levels is 
strongly correlated to induction of senescence. The contribution of 
microRNAs to the induction and maintenance of the senescent phenotype 
might involve the regulation of different cellular pathways. The most 
investigated is influencing the cell cycle progression. In this regard many 
studies show that the let-7 family of microRNAs inhibits KRAS and c-
MYC, related to cell cycle. Similarly, microRNAs 15a/16-1 cluster and 
the microRNA-17-92 cluster are potent regulators of cell cycle 
progression by targeting Cdk6 as well as the Cdk inhibitor family 
members p21
WAF1
, p27 and p57 as reviewed recently (110). Another 
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example is microRNA 34, which is under the control of p53 (111). This 
microRNA functions as a tumor suppressor and its overexpression in 
fibroblasts IMR90 induces a senescent phenotype. In murine fibroblasts 
MEF, microRNA 20 induces a senescent phenotype through upregolation 
of p16
INK4a
 (112). 
microRNAs might also be involved in the perturbation of the 
microenvironment surrounding the aged cells, by modulating secretion of 
proteins like extracellular matrix or cytokines In regard to secretion of 
cytokines, it is of note that microRNA-146a/b, which are upregulated in 
senescent fibroblasts, are inhibitors of IL-6 and thus might contribute to 
the protein secretion alterations observed in senescent cells (113).  
 
1.6 Scientific hypothesis and aim of the work 
The aim of this work was to evaluate the role of the microRNAs in the 
cellular senescence, in particular in the induction of senescence in human 
primary fibroblasts IMR90. Cellular senescence is now recognized as a 
mechanism to prevent tumorigenesis and a possible contributor to aging. 
microRNAs are regulators of gene expression at post-transcriptional level. 
Emerging evidences indicate a crucial role of microRNAs in the induction 
and maintenance of senescent phenotype. The purpose of the present 
investigation is: 
• To analyze the differential expression of microRNAs in senescent 
(late passages) relative to young human diploid fibroblasts IMR90 
(early-passage); 
• To validate these expression data in another example of replicative 
senescence in normal BJ cells and in premature senescence of 
IMR90, induced with diethylmaleate (DEM) compound, able to 
induce oxidative stress and with Etoposide, a DNA damaging 
agent; 
• To analyze the effects of the manipulations of selected upregulated 
microRNAs in young IMR90 to investigate whether the variations 
of intracellular levels of some microRNAs is a causative event of 
senescence; 
• To explore molecular mechanisms by which selected microRNAs are 
involved in the onset of the senescence, in particular by focusing on 
the pathway of the DNA damage response (DDR).  
 
 
Materials and Methods 
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2. MATERIALS AND METHODS  
 
2.1 Cell cultures and replicative senescence. 
 
IMR90 cells, human primary fibroblasts (ATCC, population doubling 
level -PDL- 25) and BJ cells, human neonatal foreskin (ATCC, PDL 24) 
were cultured in Dulbecco's modified Eagle's medium (Gibco) 
supplemented with 10% (v/v) fetal bovine serum (Gibco), 1% 
penicillin/streptomycin (Euroclone), 1% L-glutamine (Gibco). Cultures 
were maintained at 37  C in a 5% CO2-humidified atmosphere. IMR90 
cells reached replicative senescence in culture after 60 PDL and for this 
purpose, cells were continually cultured for about 3 months. BJ cells 
reached replicative senescence in culture at 66 PDL after 4 months of 
serial passages. Growths were monitored through regular counts of the 
cell number. The PDLs of cells were calculated by using the following 
equation: log2(NH/NI), where NI is the initial number of cells and NH is 
the final number of cells at each passage. Cells were plated constantly at 
a density of 5x10
5 
in 10 mm plates and splitted when the plate reaches 
90% confluence. Senescence was monitored performing the senescence-
associated β-galactosidase (SA-β-Galactosidase) assay and quantifying 
p21
WAF1
 mRNA levels. 
2.2 Induction of premature senescence in IMR90 cells by treatment 
with Diethylmaleate (DEM) and etoposide. 
 
To induce senescence with DEM (Sigma), young IMR90 cells were 
plated in complete medium at density of 7x10
5 
 in 10 mm plates. After 24 
h, DEM 100µM was added in the medium and cells were grown for 2 
days. After this time, the cells were trypsinized, counted, plated at the 
same densities and treated with the same dose of DEM. Fresh medium 
plus DEM were replaced at days 4, 6 and 8. 
To induce senescence with etoposide, young IMR90 cells were plated in 
complete medium at density of 1x10
6 
 in 10 mm plates. The next day was 
added etoposide (Sigma) directly to the culture medium at a final 
concentration of 20 M, and cells were incubated for another 24 h. Cells 
were then splitted 1:2 and cultured for 10 days. Fresh medium was 
replaced every 2 days. 
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2.3 RNA extraction and Real Time PCR for mRNA 
 
Total RNA was extracted from young/old IMR90 cells, IMR90 cells 
treated with DEM 100 M or with etoposide 20 M and BJ young/old 
cells. In brief, the cell pellet was resuspended and lysed by using Trizol 
reagent (Invitrogen). Subsequently, the lysate was mixed with an equal 
volume of chloroform and centrifugated for 5 min at 4°C at 3500 rpm. 
The supernatant was recovered, added an equal volume of isopropanol, 
and samples were centrifuged at 3500 rpm for 30 min at 4°C. The pellet 
containing the total RNA was washed repeatedly with 70% EtOH, 
centrifuged and resuspended in H2O. An aliquot of RNA was used to 
perform qualitative analysis on a denaturing polyacrylamide gel 
containing urea at a final concentration of 6M and quantitative analysis 
by spectrophotometry. 
The reverse transcriptase reaction (RT) was performed into Gene AMP 
PCR System 9700. 1 g of total RNA was denaturated at 70 °C for 10 
min and then incubated at 25 °C for 10 min with mix containing 1X RT 
buffer with 5 mM MgCl2, 5 M pdN6, 10 mM DTT, 1 mM dNTP, RNase 
inhibitor 1 U/l and Reverse Transcriptase 10 U/l (M-MLV Reverse 
Transcriptase, Invitrogen) in a final volume of 20 l. These passages are 
followed by 42C for 45 min and 99C for 3 min to degrade RNA and to 
inactivate the enzyme. The quantitative Real Time PCR was carried out 
in triplicate with an aliquot of the cDNA (1/10 of RT reactions) in the 
SYSTEM iCycler supplied of Optical System (Biorad) using iQ
TM 
Sybr 
Green Supermix in triplicate in 25 l reaction volumes. The reaction 
conditions involved a cycle at 95°C for 5 min and 40 cycles with 15 
seconds at 95°C and 1 min at 60°C (annealing and amplification). To 
quantify PCR products, Sybr Green, a dye that binds specifically double-
stranded DNA and emits fluorescence, was used. This fluorescence is 
proportional to the amount of target DNA amplified and it is revealed 
from the machine during each cycle of amplification. The fluorescence 
signal, accumulated during the PCR cycles in proportion to the 
concentration of amplificated products, defines for each gene the 'cycle 
threshold' or Ct, the number of cycles at which the fluorescence reaches a 
higher value respect to the basic signal. For the quantization was used the 
comparative Ct method by using as a reference gene c-ABL, whose 
transcript does not vary in our experimental conditions. The PCR 
reaction was conducted in 25 l of which: 12.5 l 2X Sybr Green PCR 
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Master Mix (Biorad); 0.19 s 40 M forward primer; 0.19 s 40 M 
reverse primer; 7.12 l H2O; cDNA(1/10 of RT reactions). 
The choice of the primers to use in quantitative Real-Time PCR reactions 
was performed using the program Primer Express (Perkin-Elmer). The 
sequences of the primer pairs used were: 
c-Abl forward, 5′-TGGAGATAACACTCTAAGCATAACTAAAGGT-3′;  
c-Abl reverse, 5′-GATGTAGTTGCTTGGGACCCA-3′;  
p21
WAF1
 forward, 5′-CTGGAGACTCTCAGGGTCGAA-3′;  
p21
WAF1
 reverse, 5′-CGGCGTTTGGAGTGGTAGAA-3′;  
Cyclin A forward, 5′-TGGGCACTGCTGCTATGCT-3′; Cyclin A reverse, 
5′-TTTCTTGGTGTAGGTATCATCTGTAATGT-3′; 
Thymidylate synthase (TS) forward, 5′-
GAGGAGTTGCTGTGGTTTATCAAG-3′; 
Thymidylate synthase (TS) reverse, 5′-
CCCAGGCTGTCCAAAAAGTC-3′; 
Cyclin-selective ubiquitin carrier protein (Ucar) forward, 5′-
GGGATTTCTGCCTTCCTGA-3′; 
Cyclin-selective ubiquitin carrier protein (Ucar) reverse, 5′-
GCATTGTAAGGGTAGCCACTGG-3′; Interleukin-6 (IL6) forward, 5′-
GTACATCCTCGACGGCATCTC-3′; 
Interleukin-6 (IL6) reverse, 5′-GGTTCAGGTTGTTTTCTGCCA-3′; 
Hepatocyte nuclear factor-3 (HFH-11A) forward, 5′-
AGCCCTTTGCGAGCAGAA-3′; 
Hepatocyte nuclear factor-3 (HFH-11A) reverse, 5′-
CCACTGGATGTTGGATAGGCTAT-3′.  
 
2.4 RNA extraction and analysis of human microRNAs expression 
 
Total RNAs with enriched fraction of small RNAs (200 nucleotides or 
smaller) were isolated from cultured cells with mirVana miRNA Isolation 
Kit (Ambion) following the manufacturer's instructions. TaqMan Low 
Density Arrays (TLDA)/Human microRNA Panels v1.0 (Applied 
Biosystems), designed for mature microRNA quantification was utilized 
in our studies to evaluate the microRNA expression. Each card/panel 
contains primer-probe for 365 human microRNAs present in the Sanger 
miRBase and three endogenous small RNA controls (RNU48, RNU44 
and RNU6). One hundred nanograms of RNA were reverse transcribed 
using the microRNA multiplex RT primers and the TaqMan microRNA 
reverse transcription kit (Applied Biosystems). The reaction was 
incubated for 30 min at 16°C, 30 min at 42°C, and 5 min at 85°C. Each 
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RT reaction was diluted to 0.5ng/l in the TaqMan Universal PCR Master 
Mix (Applied Biosystems) and subsequently distributed into the 
preloaded micro fluidic cards. The reactions were carried out at 50°C for 
2 min, followed by 95°C for 10 min, and then by 40 cycles of 95°C for 
15 s and 60°C for 1 min. The TaqMan PCR reactions were performed on 
an ABI Prism 7900HT qPCR system equipped (Applied Biosystems). 
Cycle threshold (Ct) values were calculated using the automatic baseline 
and the automatic threshold in RQ manager v1.1 analysis software. Data 
were quantified and analyzed using the Sequence Detection System 
software (v. 2.3) (Applied Biosystems). The value of fold change of each 
microRNA in senescent versus young cells was obtained by normalizing 
relative expression of each microRNA against endogenous control RNU6 
using the comparative ΔΔCt method. Ct values > 35 were considered to 
be below the detection level of the assay. Therefore, only the microRNAs 
with a Ct ≤ 35 were included in the analyses. 
2.5 Quantitative PCR Real-Time for microRNAs 
For quantitative analysis of microRNAs,
 
two-step TaqMan Real-Time 
PCR analysis was performed using primers
 
and probes obtained from 
Applied Biosystems. The TaqMan microRNA assay kit for specific 
microRNAs was used according to the supplier‟s protocol. 
The reverse transcriptase reaction was performed with 1 g of total RNA 
into the Gene AMP PCR System 9700, using an Applied Biosystems kit 
(MicroRNA Reverse Transcription). The reaction was conducted in 15 l 
composed of 7 l of RT Master Mix, 5 l of RNA and 3 l of specific 
primer. The protocol provides a cycle of reaction at 16 °C for 30 min, a 
cycle at 42 
o
C for 30 min and a cycle at 85 °C for 5 min. An aliquot of the 
product of reverse transcription reaction was used to perform Quantitative 
Real-Time PCR. The conditions of the reaction involved a cycle of 
reaction at 95 °C for 10 min (activation of the enzyme Taq polymerase) 
and 40 cycles of 15 seconds at 95 °C and 60 seconds at 60 °C (annealing 
and amplification). 
The PCR reaction was conducted in 20 l final in which there is: 10l 
TaqMan 2X Universal PCR Master Mix; 7.67l H2O; 1l 20X TaqMan 
microRNA assay mix; 1.33l of product of RT. RNU6 was used as an 
endogenous control for microRNAs quantification. Normalized 
expression of microRNAs was calculated by using the comparative ΔΔCt 
method. 
 
2.6 Transfection of IMR90 cells by electroporation 
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The cells were washed with 1X PBS, trypsinized, counted and 
centrifuged at 1000×g for 10 min. Cell pellet was resuspended at a 
density of 1x10
6
 cells/0,1 ml buffer R supplied by electroporation kit 
(Neon Trasfection Kit Invitrogen). Electroporation was performed with a 
MicroPorator MP 100 (Digital Bio) according to the manufacturer's 
protocol, with some modifications for IMR90 cells. Preliminary 
experiments were performed to test different conditions of 
electroporation on IMR90. The selected protocol allows a transfection 
efficiency of 70% and low SA--galactosidase activity (<5%). This 
protocol consists of 3 pulse each of 1400 Vs for 10 millisecond. For the 
transient transfections were used synthetic precursors (Applied 
biosystems) of microRNAs at a final concentration of 100 nM and a pre-
miR microRNA negative control precursor was used as a control to 
compare the activity of others pre-miRs. After transfections cells were 
seeded on different plates containing coverslips for immunofluorescence 
analysis. Immediately after electroporation was performed cell counting 
to estimate the cell mortality caused by electroporation. Since we 
observed a relatively modest mortality, cell counting was performed 
comparing number of cells at 48 h and 96 h versus adherent cells counted 
at 20 h after transfection. 
 
2.7 Bromodeoxyuridine assay 
 
The 5-Bromo-2' deoxy-uridine (BrdU) assay measures cell proliferation. 
The incorporation of BrdU into the DNA of cells is monitored using a 
specific monoclonal antibody for BrdU. After transfection, the cells were 
plated on glass coverslips and after 48 h incubated in presence of BrdU 
(Roche Diagnostics, Germany) for 48 h at final concentration 10 M. 
The cells on coverslips were fixed at -20°C for 30 min with the ethanol 
fixative solution (70% EtOH in glycine, pH 2,0 ) that also permeabilizies 
the cells. After washing three times with PBS 1X (Roche Diagnostics, 
Germany) BrdU was detected by covering the cells with the anti-BrdU 
solution (Roche Diagnostics) for 30 min at 37°C. After washing, the cells 
were incubated with Alexa Fluor 488-labeled goat antimouse IgG 
antibody (Invitrogen, Molecular Probes) for 30 min at 37°C, and then 
washed three times with PBS 1X. The slides are mounted using 10 l of a 
mounting medium that has a counterstain DAPI (4,5 diamidino-2-
phenylindole; blue) (Vectashield) that was used to calculate the total 
number of cells because DAPI counterstained the nuclei. 
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2.8 Assay for β-galactosidase activity in situ 
 
In situ SA-β-galactosidase staining with 5-bromo-4-chloro-3-indolyl b-
D-galactoside (X-gal) was performed as following: the cells were fixed 
in PBS 1X containing 2% formaldehyde and 0.2% glutaraldehyde for 5 
min at room temperature, washed twice with PBS, and then incubated for 
24 h at 37°C with 1 mg/ml X-gal dissolved in 40 mM citric acid/sodium 
phosphate pH 6.0, 5 mM potassium ferrocyanide, 5 mM potassium 
ferricyanide, 150 mM NaCl and 2 mM MgCl2. The positive cells were 
photographed thereafter and scored by
 
assessing at least 300 cells in 
many random fields/plates.  
 
2.9 Comet assay 
 
DNA damage was evaluated with the Comet assay that was performed 
according to the manufacturer's protocol. Briefly, transfected cells were 
washed with PBS 1X, trypsinized, harvested and resuspended in cold 
PBS 1X. The same procedure was performed on IMR90 cells treated 
with etoposide at 300 µM for 4 h, that were used as a positive control. 
5×10
3
 cells were combined with molten Comet LMAgarose (1% low-
temperature
 
melting agarose, Trevigen, Gaithersburg, MD, USA) at a 
ratio
 
1:10 (v/v). 60 µl of the mixture was immediately placed on a 
CometSlide
 
(Trevigen) and allowed to solidify at 4°C for 20 min. Then 
cells were lysed by immersing the slides in lysis solution provided by the 
kit at 4°C for 1 h. Slides were then immersed in a freshly prepared 
alkaline solution (pH >13) for 40 min and run on a horizontal 
electrophoresis apparatus for 30 min. After washing in 70% ethanol, the 
slides were air-dried and kept in the dark until analysis. Cells were 
visualized by adding 40 μl of diluted SYBR green and observed under 
fluorescent microscope. Quantitative analyses of the results were done by 
using the Image software (National Institutes of Health, Bethesda, MD, 
USA), as suggested by the manufacturer. Tail moment (TM) was used as 
descriptor of DNA damage. The tail moment is defined as the product of 
the tail length and the fraction of total DNA in the tail (TM = tail length x 
% of DNA in the tail). The comet assay analysis allowed the separation 
of cells with different categories of DNA damage depending on TM 
value damage. For these experimental conditions, cells with TM ≤ 20 
(99% in the negative control of transfected miRs) were regarded as 
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undamaged (comet classe 0); cells with TM > 20 were considered 
damaged (comet classes I-V). 
 
2.10 Western blot analysis 
 
Harvested cells were washed twice with ice-cold PBS and centrifuged at 
1000×g for 10 min at 4 C. The cell pellet was resuspended in 100μl of 
ice-cold lysis buffer (0.02 M
 
HEPES pH 7.9, 0.4 M NaCl, 0.1% NP-40, 
10% glycerol,
 
1 mM NaF, 1 mM sodium orthovanadate and a protease 
inhibitor
 
cocktail). To detect the presence of phosphorylated protein, the 
buffer for cellular lysis was different: 50 mmol/L HEPES (pH 7.5), 150 
mmol/L NaCl, 10% glycerol, 1% Triton X-100, 1 mmol/L EGTA, 1,5 
mmol/L MgCl2, 10 mmol/L NaF, 10 mmol/L sodium PPi, 1 mmol/L 
Na3VO4, 10 g/ml aprotinin and 10 g /ml leupeptin. After resuspension, 
the mixture was clarified by centrifugation at 10000 x g and the 
supernatant was then used for western blot. Protein concentrations were 
determined by a Bio-Rad (Italy) protein assay kit. Extracts were 
subjected to sodium dodecyl sulfate
 
(SDS)-polyacrylamide gel 
electrophoresis, followed by blotting
 
to nitrocellulose. The blots were 
probed with antibodies against p21
WAF1
(Santa Cruz Biotechnology), 
p16
INK4a
(Santa Cruz Biotechnology), GAPDH (Santa Cruz 
Biotechnology), tubulin (Santa Cruz Biotechnology) and phosporylated 
CHK1 and CHK2 (Cell signalling) and the signals were detected by 
using the ECL kit (Amersham Biosciences). 
 
 
 
Results 
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3. RESULTS 
3.1 Characterization of replicative senescence in IMR90 
IMR90 is a primary cell line of fibroblast derived from human fetal lung 
that reaches cellular senescence after approximately 60 duplications in 
vitro. We generated IMR90 senescent cells by serial passages in vitro 
until the cells exited cycling and acquired a clear senescent phenotype. 
Figure 5, panel A shows a representative growth curve of IMR90. The cell 
growth rate was evaluated by calculating PDL (population doubling level) 
as described in Materials and Methods. Growth curves display a period of 
exponential trend: in fact up to 45 PDL these cells grow quickly and then 
begin to slow down and finally after 80 days of culture cells reach a 
plateau, during which they do not divide but remain metabolically active. 
To test the senescent phenotype, we evaluated several markers of the 
senescence such as the appearance of -galactosidase activity and the 
expression levels of some genes related to cell cycle and senescence (6). 
-galactosidase is a lysosomal enzyme that in senescent cells accumulates 
in the cytoplasm and in certain conditions of acid pH (pH 6) its activity 
can be observed using a chromogenic substrate, 5-bromo-4-chloro-3-
indolyl b-D-galactoside (X-gal), that triggers the formation of blue 
detectable precipitates. The image in the panel B of figure 5 shows that 
the accumulation of intracellular -galactosidase activity is proportional 
to the cumulative PDLs. Furthermore, senescent cells appear 
morphologically different compared to young cells with an enlarged and 
flattened morphology. 
To further confirm the induction of replicative senescence in IMR90 cells, 
we evaluated the expression profiles of some genes involved in cell cycle 
regulation, such as cyclin A, thymidylate synthase (TS), p21
WAF1
 and 
hepatocyte nuclear factor-3 (HFH-11A), or in pro-inflammatory network 
(interleukin 6, IL6) as well as in proteasome activity (cyclin-sensitive 
ubiquitin carrier protein, Ucar). The results were obtained through a 
quantitative Real Time PCR on total RNA extracted from IMR90 cells at 
PDL 35 (young control) and IMR90 cells at PDL 60 (senescent cells). 
The Figure 5, panel C shows that the mRNAs encoding for cyclin A, 
thymidylate synthase, Ucar and HFH-11A are many fold decreased in 
senescent cells compared to young cells, on the contrary p21
WAF1 
 and IL6 
mRNA levels significantly increased. The results are in agreement with 
their role in the proliferative exhaustion of senescence.  
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Finally, the levels of p16
INK4a
 and p21
WAF1
 proteins were assessed by 
western blot analysis. The panel D in the Figure 5 shows up-regulation of 
these proteins in IMR90 at PDL 60 indicating a persistent state of cell 
cycle block.  
 
 
 
 
Figure 5: Characterization of replicative senescence in IMR90. 
A) Representative growth curve of primary human IMR90 fibroblasts. Cells at low passages 
(PDL 24- Population Doubling Level-) obtained from ATCC were continually cultivated 
until the culture acquired senescence (PDL 60). Cells were plated constantly at a density 
of 5x10
5 
in 10 mm plates and splitted when the plate reached 90% of confluence. The 
total cell number at each subcultivation was counted and PDL calculated using the 
equation X=log2 NH/NI; NH= final cell number, NI= starting cell number. 
B) SA--galactosidase staining at different PDLs and relative percentage of coloration. SA--
galactosidase activity is highlighted by the blue color present in the cytoplasm of cells. 
The percentages values are obtained by scoring at least 300 cells on the plates. The 
images also show the different morphology of senescent cells, that appear more 
flattened, enlarged and granular compared to young cells. 
C) Changes in mRNA levels of some genes related to cell cycle and senescence. The values 
in the histogram were obtained by quantitative Real Time PCR comparing the relative 
mRNA levels of each gene of senescent cells (PDL 60) with those of young cells (PDL 
35).For the quantization was used the comparative CT method, using as a reference 
gene c-ABL whose transcript does not vary in our experimental conditions. p21
WAF1
(p21), 
cyclin A, thymidylate synthase (TS), cyclin-sensitive ubiquitin carrier protein (Ucar), 
interleukin-6 (IL6) and hepatocyte nuclear factor-3 (HFH-11A)  
D) Western Blot analysis of p21
WAF1
 and p16
INK4a
, two CDK inhibitors, in total protein extracts 
prepared from young and senescent IMR90 cells.  An antibody against GAPDH was used 
for normalization. 
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3.2 microRNA expression profiles in senescent IMR90 fibroblasts 
 
To assess the expression profile of microRNAs (miRNAs, miRs) in 
senescent cells we have analyzed a microRNA microarray that probes the 
expression of 365 known human microRNAs by using RNA extracted 
from IMR90 senescent cells at PDL 60 and young cells at PDL 35. 
Experiments were carried out in collaboration with the laboratory of prof. 
M. Santoro of the Department of Cellular and Molecular Pathology. We 
used the Taqman Low Density Array (TLDA) that enables the 
quantitative Real-Time PCR precision in a low-density array format. In 
each card there are 365 human microRNAs primers spotted and three 
small RNA controls (RNU48, RNU44 and RNU6). In our microarray 
study we considered expressed those microRNAs that showed the 
threshold-cycle (Ct) values below 35 (Ct<35). Applying these criteria 
179 microRNAs out of the 284 analyzed were found to be expressed in 
IMR90 cells. Relative microRNA expression was normalized against the 
endogenous control RNU6. When compared to young IMR90 cells, 
senescent IMR90 cells revealed that 47% of microRNA were down-
regulated (at least 2 fold) and 19% were up-regulated. It is clear that most 
of the microRNAs present in the cards do not show changes in their 
expression levels in senescent cells. The complete set of expression data 
is reported in Table I. 
Among them, we chose to perform further investigations on microRNAs 
showing higher modifications and with high/medium abundances (below 
the threshold-cycle value Ct 35), more suitable for accurate microarray 
data analysis. 
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Table I: microRNA expression profiles in senescent IMR90 fibroblasts  
To assess the expression levels of microRNAs in human senescent IMR90 cells compared to young 
IMR90 cells was used TaqMan Low Density Arrays TLDA (v 1.0). This method enables the 
quantitative Real-Time PCR precision in a low-density array format. In each card there are 365 
human microRNAs spotted and three small RNA controls (RNU48, RNU44 and RNU6). The results 
reported in the table I are for the 179 expressed microRNA identified in the cards. For the 
quantization the comparative CT method was performed using as reference the endogenous 
control RNU6 by using the SDS RQ manager v1.2 software (Applied Biosystems). Effective analysis 
of these 179 microRNAs shows that 34 microRNAs are up-regulated in senescent cells versus 
young IMR90 cells and 84 microRNA downregulated (at least 2 fold).  
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3.3 Validation of microRNA profile in senescent IMR90 fibroblasts  
 
Validation was performed on a selection of the microRNAs identified as 
differentially expressed by TLDA microarray analysis. We focused on 
microRNAs showing robust expression (Ct value  35), which were at 
least twofold up- or down-regulated. This group included 22 microRNAs 
derived from the screening that increased in senescent IMR90 cells, 14 
microRNAs that decreased during senescence and 2 microRNAs that 
resulted unchanged (endogenous controls). Selected microRNAs were 
examined individually by performing quantitative real-time PCR (qRT-
PCR) with sequence-specific primers in three different populations of 
RNAs from young and senescent IMR90 cells. Overall over 80 percent of 
the microRNAs tested were validated, thus confirming the results 
generated by the microarray analysis. As shown in Table II, we found that 
expression of several upregulated microRNAs selected for validation 
(miR-23b, miR-30e-5p, miR-126*, miR-134, miR 200c, miR-210, miR-
369-3p, miR-376a*, miR-379, miR-410, miR-432, miR-485-5p, miR-
486, miR-494, miR-542-5p, miR-654 and miR-656), were markedly 
more abundant in senescent cells as well as selected downregulated 
microRNAs (miR-7, miR-15b, miR-17-5p, miR 19b, miR-20a, miR-92, 
miR-93, miR-155, miR 199b, miR-296) were expressed at lower levels in 
senescent cells. In many cases we observed that related microRNAs, for 
example microRNAs expressed in polycistronic clusters, showed similar 
expression profiles. In fact, a common downregulation of members of the 
17-92 cluster as well as of the paralogous miR-106 family was found. 
Interestingly, these clusters very recently were reported to be involved in 
aging process (114). Similarly, miR-134 (also known as miR-127), miR-
369-3p, miR-376a*, miR-379, miR-410, miR-432, miR-485-5p, miR-
494, and miR-654, that are overexpressed in senescent IMR90, reside on 
an imprinted region of human chr. 14q32, that contains more than 50 
members and has been found as the largest microRNA cluster to date.  
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Table II: Validation of senescence-associated microRNA profiles in IMR90 cells. 
TaqMan microRNA assays (Applied Biosystems) were performed on selected microRNAs to 
validate the microarray results. For the analysis, microRNAs that were significantly upregulated or 
downregulated (at least 2 fold) in IMR90 PDL60 versus PDL 35 and expressed at Ct < 35 were 
chosen. The reported fold changes were normalized to RNU6. The data shown are the mean ± 
standard deviation of three independent experiments carried out on three different populations of 
IMR90 derived from three different original cultures. The microRNAs in the table are listed according 
to their descending fold change values. The chromosomal localization of the microRNA is also 
indicated. 
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3.4 Senescence-associated microRNA profiles in BJ cells and in 
premature senescent IMR90 cells  
 
To assess whether these microRNAs alterations are more closely related 
to replicative senescence of IMR90 or may be considered as a common 
phenomenon in other types of replicative or premature senescence, we 
used another example of replicative senescence obtained in BJ cells, a 
human cell line from foreskin fibroblasts that reach a state of senescence 
after a greater number of cell duplication (PDL 66). As shown by Figure 
6 both the phenotype and the evolution of senescence markers are very 
similar to IMR90. Indeed, in the panel A it is showed that the 
accumulation of intracellular -galactosidase activity is comparable to -
galactosidase activity in IMR90 cells. Also the expression profiles of 
genes involved in cell cycle regulation, such as cyclin A, thymidylate 
synthase (TS), p21
WAF1
 and HFH-11A, or in pro-inflammatory network 
(interleukin 6, IL6) as well as proteasome activity (cycline-sensitive 
ubiquitin carrier protein) and the protein levels of p21
WAF1
 and p16
INK4a
 
are similar to those observed in senescent IMR90 cells (Figure 6, panels 
B and C).  
We quantified the levels of those microRNAs that showed significant 
expression differences based on the microarray results and that were 
validated in senescent IMR90 cells. qRT-PCR for single mature 
microRNAs was employed to compare microRNA expression patterns of 
senescent (PDL 66) BJ cells versus young proliferating cells (PDL 30). 
As shown by Figure 6, Table III, in BJ cells, with the exception of miR-
410 and miR-654 (up-regulated), miR-199b and miR-296 (down-
regulated), that showed s less pronounced change in senescent BJ cells, 
all other microRNAs showed a general trend of variations that 
overlapped with IMR90 cells. These results indicate that these selected 
up- or down-regulated microRNAs exert a biological action in the 
senescence program.  
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Figure 6: Senescence-associated microRNA profiles in BJ cells. 
A) Representative images of SA--galactosidase staining in primary human BJ cells at PDL 30 and 
PDL 66 and relative percentage of coloration. SA--galactosidase activity is highlighted by the blue 
color present in the cytoplasm of cells. The values of the percentages are obtained by scoring at 
least 300 cells on the plates. 
B) Changes in mRNA levels of some genes related to cell cycle and senescence. The values in the 
histogram were obtained by quantitative Real Time PCR comparing the relative mRNA levels of 
each gene of senescent cells (PDL 66) with those of young cells (PDL 30). For the quantization was 
used the comparative CT method, using as a reference gene c-ABL whose transcript does not 
vary in our experimental conditions. p21
WAF1
, cyclin A, thymidylate synthase (TS), cyclin-sensitive 
ubiquitin carrier protein (Ucar), interleukin-6 (IL6) and hepatocyte nuclear factor-3 (HFH-11A). 
C) Western Blot analysis of p21
WAF1
 and p16
INK4a
, two CDK inhibitors, in total protein extracts 
prepared from young and senescent BJ cells. An antibody against GAPDH was used for 
normalization. 
Table III: TaqMan microRNA assays (Applied Biosystems) were performed on selected microRNAs 
to assay their expression levels in replicative senescent BJ cells (PDL66 versus PDL30). The 
reported fold changes were normalized to RNU6. The data shown are the mean ± standard 
deviation of three independent experiments.  
 
 35 
 
Because senescence in human cells can be triggered
 
by both intrinsic 
factors such
 
as telomere regression and extrinsic factors such as 
oncogenic stress, DNA damage, and oxidative stress, we determined 
microRNA expression signatures in IMR90 premature senescence 
induced by chronic oxidative stress (SIPS) or by DNA damaging agent 
(DDPS). To ﬁnd common participants involved in senescence, young 
IMR90 fibroblasts (PDL35) were chronically exposed for 10 days to low 
doses of the GSH-depleting agent DEM (100 M) (115) or treated for 24 
h with etoposide (20 M) and then maintained in culture for 10 days (see 
Materials and Methods). Under these conditions, IMR90 cells acquired a 
senescent phenotype resembling that observed after serial in vitro 
passages, as confirmed by the analysis of the expression profiles of genes 
involved in cell cycle regulation or in pro-inflammatory network as well 
as proteasome activity that are similar to those observed in replicative 
senescent IMR90 cells (Figure 7 panels A, B). Also, the levels of p21
WAF1
 
proteins were assessed by western blot analysis and these levels are 
increased after treatments (Figure 7 panels C). The microRNA expression 
signatures in DEM-senescent and in etoposide-senescent IMR90 
compared to untreated cells, carried out by qRT-PCR method, is 
summarized in Figure 7, Table IV. In IMR90 cells treated with DEM 100 
M or etoposide 20 M, with the exception of miR-200c, miR-542-5p 
and miR-656 that were unchanged in both conditions (cut off 1,5 fold), 
most of the microRNAs analyzed in SIPS and DDPS showed similar 
expression modifications relative to in vitro exhaustion of replicative 
capacity. 
In this part of the study we were able to identify a large set of 
microRNAs, the expression of which constitutes a recurring signature of 
senescence, independently from cellular context and stimuli. These 
results indicate that senescence follows a common molecular program in 
microRNA expression. 
 36 
 
 
 
Figure 7: Senescence-associated microRNA profiles in premature senescent IMR90 cells  
A) Representative images of SA--galactosidase staining in IMR90 cells at PDL 35 (control cells), 
after treatment with 100 M DEM for 10 days or 20 M etoposide for 24 h, splitted 1:2 and left in 
culture for 10 days and relative percentage of coloration. SA--galactosidase activity is highlighted 
by the blue color present in the cytoplasm of cells. The values of the percentages are obtained by 
scoring at least 300 cells on the plates.  
B) Changes in mRNA levels of some genes related to cell cycle and senescence after 10 days of 
treatment with 100 M DEM and after treatment with 20 M etoposide for 24 h and cultured for 10 
days. The values in the histogram were obtained by quantitative Real Time PCR comparing the 
relative mRNA levels of each gene of treated cells with those control cells. For the quantization was 
used the comparative CT method, using as a reference gene c-ABL whose transcript does not 
vary in our experimental conditions. p21
WAF1
, cyclin A, thymidylate synthase (TS), cyclin-sensitive 
ubiquitin carrier protein (Ucar) and interleukin-6 (IL6).  
C) Western Blot analysis of p21
WAF1
, a CDK inhibitors, in total protein extracts prepared from 
treated cells and control cells. An antibody against tubulin was used for normalization. 
Table IV: TaqMan microRNA assays (Applied Biosystems) were performed on selected microRNAs 
to assay their expression levels in premature senescent induced in IMR90 with treatment with 100 
M DEM and 20 M etoposide. The reported fold changes were normalized to RNU6. The data 
shown are the mean ± standard deviation of three independent experiments.  
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3.5 Overexpression of some selected up-regulated microRNAs 
inhibits cell growth in IMR90 cells 
To investigate whether the variation of levels of these microRNAs is a 
causative event of senescence or a consequence of intracellular pathway 
disturbance after the onset of senescence, we set up functional 
experiments. Since most of the studies have focused on downregulated 
microRNAs, we decided to overexpress selected upregulated microRNA 
in young IMR90 with the rational that elevated levels of these 
microRNAs could induce a senescence program. 
To this aim we transfected synthetic precursor of microRNAs (pre-miRs, 
Applied Biosystems) in IMR90 cells at PDL 35. For transfection 
experiments we selected 12 upregulated microRNAs (miR-30e-5p, miR-
126*, miR-200c, miR-210, miR-376a*, miR-369-5p, miR-379, miR-432, 
miR-486, miR-494, miR-542-5p, miR-654), and an unmodified 
microRNA (miR-32). 
The precursors used are double-stranded RNAs chemically modified, 
designed to be incorporated into the effector complex RISC and thereby 
mimic endogenous mature microRNAs. As shown in Figure 8, panel B, a 
Cy3 dye-labeled negative pre-miR allows the monitoring of transfection 
efficiency, that was calculated 70% in our experimental conditions.  
To obtain a quantization of levels of mature microRNAs and a time-
course of its maturation, we performed quantitative Real Time PCR on 
RNA extracted from transfected cells at 24 h, 48 h and 96 h after 
transfection, using specific TaqMan probes (Applied Biosystems). As 
shown in Figure 8, panel C, the intracellular levels of representative 
mature microRNAs (miR-210) significantly increased in cells transfected 
with the pre-miRNA (300-500 fold) and peaks at 48 h after transfection.  
To analyze the effects of the different pre-miRs in young IMR90 cells 
(PDL 35), we analyzed various parameters related to the senescent 
phenotype. First, we evaluated cell proliferation by performing cell 
counting at 48 h and 96 h after transfection and compared them to the 
number of adherent cells at 24 h. As shown in Figure 8, panel A, the 
number of cells transfected with pre-miRs 210, 376a*, 486, 494, 542-5p 
and 654, at 48 h and 96 h after transfections shows a clear reduction of 
growth, already at 48 h after transfection, which persist at 96 h. On the 
contrary, some pre-miR overexpressions (pre-miRs 30e-5p, 32-
unchanged control-, 126*, 200c, 369, 379 and 432) have no effect on cell 
growth of young IMR90 cells.  
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Figure 8: Overexpression of some selected up-regulated microRNAs inhibits cell growth in IMR90 
cells  
A) Cell counting. Transient transfections with precursor molecules of microRNAs (pre-miRs) that 
were up-regulated in senescent cells were made in young IMR90 (PDL 35) cells. Pre-miRs were 
used at a final concentration of 100 nM. A pre-miR miRNA negative control precursor were used as 
a control to compare the activity of others pre-miRs. Histograms show the fold variations of cell 
number obtained by comparing the number of adherent cells at 48/96 h with the number of adherent 
cells at 24 h after transfection. The data obtained are the mean ± standard deviation of at least 
three independent experiments.  
B) Pre-miRs transfection efficacy. Cy3 dye-labeled pre-miR Negative Controls (Ambion) was 
viewed with a fluorescent microscope at 24 h after transfection. Nuclei are been displayed with 
DAPI.  
C) Representative Taq-Man assay performed on miR-210 to assay its expression levels and a 
time course of its maturation in transfected IMR90 young cells at 24 h, 48 h and 96 h after 
transfections. The reported fold changes were normalized to RNU6.  
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This demonstrates that it is not the overexpression of microRNA per se 
and consequently the perturbance of the microRNA processing 
machinery that blocks cell growth.  
To assess the amount of cells that are in active proliferation, we analyzed 
the incorporation of bromodeoxyuridine (BrdU), an analogue of thymine 
that is incorporated during DNA synthesis after transfection of cells. 
Because IMR90 young cells have a relatively long doubling time (about 
36 hours), we incubated the cells with BrdU for 48 h. 
Immunofluorescence experiments using an antibody directed against 
BrdU were performed at 96 h after transfections. Figure 9, panel A 
indicates that cells transfected with pre-miR 210, 376a*, 486, 494, 542-
5p, 654 have a remarkable reduction of DNA synthesis, perhaps 
associated with a block of cell cycle in G1 phase. On the contrary, cells 
transfected with pre-miRs 30e-5p, 32, 126*, 200c, 369, 379 and 432 have 
a rate of incorporation of BrdU similar to that observed in cells 
transfected with pre-miR negative control. Representative 
immunofluorescence are presented in Figure 9, panel B. 
The data reported indicate that some selected microRNAs found 
overexpressed in the initial screening inhibit cell growth, probably in 
G1/S phase. It is important to specify that in one case, miR-654, the 
amount of alive cells after 96 h from transfection is much lower in 
comparison to the amount of alive cells at 24 h and in the other samples 
at the same time, indicating that the most important role of this 
microRNA could be related to cell death. 
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Figure 9: Bromodeoxyuridine (BrdU) labeling in cells over-expressing selected microRNAs  
A) Quantitative analysis of BrdU positive cells. Histograms show the percentage of BrdU-positive 
IMR90 cells transfected with different pre-miRs evaluated at 96 h after a 48 h of pulse time. The 
data obtained are the mean ± standard deviation based of three independent experiments. 
B) Assay of BrdU incorporation in cells transfected with pre-mirS. The images show 
representative transfected cells immunostained with anti-BrdU antibody and counter stained with 
DAPI to visualize DNA. Images were collected by fluorescent microscopy.  
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3.6 Overexpression of some selected microRNAs induces a 
senescent-like phenotype 
 
From the above experiments resulted that various microRNAs (miR-210, 
miR-376a*, miR-486, miR-494, miR-542-5p and miR-654) are able to 
inhibit cell cycle progression with reduced BrdU incorporation. To test 
the hypothesis that these microRNAs are able to induce the senescence 
program, we analyzed the -galactosidase activity, more linked to 
senescence in cells transfected with these microRNAs. To this aim we 
performed -galactosidase staining in cells overexpressing the above 
mentioned pre-miRs at 7 days after transfection. Quantification of the 
data showed that the -galactosidase activity in cells transfected with 
pre-miRs 210, 376a*, 486, 494, 542-5p significantly increases, with 
staining values that range from 10 to 25 positiveness percentage 
compared to 1 percent of the control, as shown in Figure 10, panel A. 
Representative SA--galactosidase staining of cells transfected with 
these microRNAs are presented in Figure 10, panel B. 
Another evidence of the induction of senescence comes from the 
morphology of the transfected cells, at least in those with more elevated 
-galactosidase activity. These cells show enlarged cell size, a loss of 
filamentous morphology typical of human fibroblasts and an irregular 
cellular margin. Cells transfected with pre-miR 486 instead show an 
unusual phenotype with small size and a reduced cytoplasm. Cells 
transfected with pre-miR 654 are numerically lower compared to other 
cells and show a pyknotic and very stressed morphology.  
Following data were obtained in collaboration with the group of prof. M. 
Santoro of the department of Biology and Cellular and Molecular 
Pathology. The data concerned the presence of senescence-associated 
foci (SAHFs) by immunofluorescence experiments in cells transfected 
with above mentioned pre-miRs at 7 days after transfection. The presence 
of SAHFs at 7 days was visualized by using an anti-3meH3K9 antibody. 
This immunofluorescence analysis shows the presence of SAHFs in 8-
21% of IMR90 cells transfected with pre-miRs 210, 376a*, 486, 494, and 
654, compared to 4% of negative control and compared to 36% of 
positive control, such as IMR90 cells at PDL 60 (data not shown). 
The results reported above indicate that the overexpression of the pre-
miRs 210, 376a*, 486, 494, 376a*, 542-5p and 654 could be correlated 
with the onset of senescence.  
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Figure 10: Overexpression of selected microRNAs induces a senescent-like phenotype  
A) Quantification of SA--galactosidase-positive IMR90 cells transfected with selected pre-miRs 
analyzed at 7 days after transfection. The data obtained are the mean ± standard deviation of three 
independent experiments. At least 300 cells were scored for quantification of positive cells. 
B) The images show SA--galactosidase activity in representative IMR90 cells transfected with 
the pre-miRNAs, which showed elevated -galactosidase activity.  
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3.7 Senescent-like phenotype is related to a persistent DNA damage 
 
Given that senescence program encompasses a canonical DNA damage 
checkpoint, we next investigated whether microRNA-induced senescence 
in IMR90 cells is correlated with the DNA damage. 
To evaluate the extent of DNA damage induced by the microRNAs, we 
used comet assay in alkaline conditions detecting both single strand 
breaks (SSB) and double strand breaks (DSB). DNA strand breaks in 
transfected cells were quantified using imaging software analysis by 
calculation of tail moment (TM), the product of the percentage of DNA 
in the tail and tail length (TM = tail length x % of DNA in the tail). Data 
collected for each population of etoposide-treated cells (positive control) 
and transfected cells showed different categories of DNA damage 
depending on TM value damage. Comet images illustrating the visual 
scoring classiﬁcation are showed in Figure 11, panel B. The data 
analysis, reported in Figure 11, panel A, detects damaged DNA (cells 
with TM > 20) in 8-40% of IMR90 cells transfected with miR-210, miR-
376a*, miR-486, miR-494, miR-654, compared to less than 1% of pre-
miR negative control (TM < 20) at 96 h after transfection. Remarkably, 
for some of these microRNAs not only the damage persists at 7 days but 
it also increased (miR-210, miR-486, miR-494). 
Other data obtained in collaboration with the group of prof. M. Santoro 
have confirmed these results. The data concerned the presence of histone 
H2AX phosphorylated (H2AX) by immunofluorescence experiments in 
cells transfected with above mentioned pre-miRs at 7 days after 
transfections. This is the histone H2A-variant that becomes 
phosphorylated (in serine 139) in chromatin regions flanking double 
strand breaks (DSB) sites and it is used as a marker of persistent DNA 
damage. This immunofluorescence analysis shows the presence of 
H2AXs in 28-34% of IMR90 cells transfected with pre-miRs 210, 486, 
494 and 654 compared to 12% of negative control (data not shown). 
We also investigated if markers of DNA damage such as phosphorylated 
CHK1 and CHK2 are present in cellular extracts from transfected cells at 
96 h after transfections. Very preliminary results obtained by western 
blot analysis showed the presence of phosphorylated CHK1 and/or 
CHK2 in cells overexpressing the above mentioned microRNAs (data not 
shown). 
Together, our data indicate that miR-210, miR-376a*, miR-486 and miR-
494 induced cellular senescence that may be mediated in part by 
activation of DNA damage pathway.  
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Figure 11: Senescent-like phenotype is related to activation of a persistent DNA damage  
A) DNA damage quantification in IMR90 cells transfected with the different pre-miRs. Histograms 
show the percentage of cells having tail moment (TM) > 20 at 96 hours and 7 days after transfection 
with the indicated pre-miRs. Cells treated with etoposide 300 μM for 3 hours were used as a 
positive control. The tail moment is defined as the product of the tail length and the fraction of total 
DNA in the tail and it is calculated automatically by the computer software system for each cell 
analyzed (we scored at least 100 cells). For these experimental conditions, cells with TM ≤ 20 were 
considered as undamaged (comet classe 0); cells with TM >20, were considered damaged (comet 
classes I-V).  
B) The images show the visual scoring classiﬁcation. Classes represent increasing DNA damage 
reﬂected by the increasing tail moment.  
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3.8 Prediction of targets of Senescence-Associated microRNAs (SA-
microRNAs) involved in pathway correlated to cellular senescence. 
 
We examined pathways involved with cellular senescence that could be 
regulated by SA-microRNAs, in particular we analyzed putative targets 
for four regulatory pathways: regulation of cell cycle/growth arrest, 
chromatin remodeling, DNA damage/repair and apoptosis.  
We have researched predicted targets using the algorithm Targetscan 
(htpp://www.targetscan.org). From Table V it is obvious that most of the 
predicted targets are related to cell cycle/growth arrest pathways. 
Remarkably, some microRNAs (376a*, 494) may also target mRNAs 
involved in the repair of DNA damage. This evidence is in accord with 
our results that demonstrate that the induction of like-senescence 
phenotype after transfection of microRNAs is related to a persistent DNA 
damage. miR-376a* targets the polymerase mRNA theta that cooperates 
with polymerase beta in base excision repair of oxidative DNA damage 
(116). miR-494 targets the Cul4a mRNA. This protein is involved in the 
repair of DNA damage: in fact Cul4a is associated with other molecules 
to form the complex cullin-RING ubiquitin E3-ligase (CRL), which is 
recruited at sites of DNA damage and also is important for subsequent 
DNA repair. 
Furthermore, despite miR-210 does not target known DNA-damage 
related mRNAs, it was recently reported that ISCU (Iron Sulfur Cluster 
homolog) proteins, involved in mitochondrial function, are targets of this 
microRNA (118). This leads to increased ROS, thereby affecting DNA 
homeostasis. Interestingly, microRNA 654, which induced a decrease in 
cell number in IMR90 after transfection, targets a mRNA involved in 
apoptosis, TRAF 4 that acts as anti-apoptotic factor and its reduction 
correlates with an increase of apoptosis. 
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Table V: Prediction of targets of Senescence-Associated microRNAs (SA-microRNAs). 
Predicted targets of SA-microRNA involved in 4 pathways related to cellular senescence (growth 
arrest/cell cycle, DNA damage/DNA repair, chromatin remodeling, apoptosis). For the prediction 
Targetscan algorithm (www.targetscan.org) was used. ISCU and NDUFA4 are in italic because they 
are indirectly related to DNA damage. 
 
 
 
 
 
Discussion 
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4. DISCUSSION/CONCLUSIONS 
MicroRNAs (miRNAs or miRs) are small non-coding RNAs that act as 
post-transcriptional regulators of gene expression, resulting in 
suppression of translation or degradation of target mRNAs. It is believed 
that around 60% of human genes coding for proteins are regulated by 
microRNAs. microRNAs resemble the transcription factors that influence 
many cellular responses because each microRNA can have up to 
hundreds of targets. Consistent with this, microRNAs are involved as 
regulators virtually in many networks, including development, 
proliferation, apoptosis and cancer. Similarly, emerging evidence indicate 
a role for microRNAs in regulating senescence.  
We explored the involvement of microRNAs in the induction and 
maintenance of cellular senescence.  
The results presented in this thesis show that several microRNAs are 
differentially expressed during replicative senescence of primary human 
IMR90 cells. These data were then validated by Real Time PCR 
experiments in replicative senescent cells derived from fetal lung 
(IMR90) or neonatal foreskin (BJ) and in premature senescence induced 
in young IMR90 cells by oxidative stress caused by DEM or DNA 
damage induced by etoposide. 
We have chosen 12 microRNAs up-regulated in senescent cells to study 
their functional role in the induction of the senescent phenotype. To this 
purpose we performed overexpression experiments in IMR90 cells at 
PDL 35 (young fibroblasts) by transfecting synthetic precursors of 
selected microRNAs (pre-miRs). Thus, we evaluated markers of cellular 
senescence following the overexpression of these microRNAs. Our 
results have shown that many selected upregulated microRNAs induce 
growth arrest and block of DNA synthesis already at 96 hours after 
transfections, at which time there is greater activity of the transfected 
microRNAs.  
Furthermore we evaluated -galactosidase activity. Some microRNAs 
(miR-210, miR-376a*, miR- 486, miR-494, miR-542-5p, miR-654) 
appear to play a causative role in senescence: cells transfected with these 
pre-miRs acquire a senescent-like phenotype as demonstrated by the 
presence of -galactosidase activity and by presence of several molecular 
markers, such as SAHFs. 
One of the principal causes of senescence is the presence of DNA 
damage not repairable. Here we investigated whether overexpression of 
selected microRNAs coincides with the presence of DNA damage that 
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mainly governs the induction and the establishment of senescence. The 
extent of DNA damage analyzed by comet assay and immunofluorescent 
experiments for specific foci of H2AX show that in some cases the 
damage induced by overexpression of microRNAs persists at 7 days after 
transfection. This could be the critical determinant that leads some 
microRNAs (miR-210, miR-376a*, miR-486, miR-494 and miR-654) to 
induce a senescent-like phenotype. 
Finally, senescence-inducing molecular pathways in which these 
microRNAs may be involved were proposed using computational target 
prediction algorithms. We focused on 4 pathways related to cellular 
senescence: cell cycle/growth arrest, chromatin remodeling, apoptosis 
and DNA damage. Many predicted target mRNAs are linked to these 
different pathways, in particular to cell cycle. It will be of interest to 
explore if these proteins are downregulated after overexpression of these 
pre-miRs. Taken together, the functions of senescence-associated 
microRNAs need to be better investigated. It would be also important to 
see if a reduced expression of these microRNAs in pre-senescent cells 
implies a delay in the induction of senescent phenotype. 
Another aspect that remains to be investigated is the study of microRNAs 
resulting downregulated from the screening. For these microRNAs we 
propose that functional experiments can be performed by using anti-miR 
in young IMR90 cells to reduce endogenous microRNA levels and to 
analyze if they or some of them are able to induce a senescence 
phenotype. Furthermore it could be of interest to explore if 
overexpression of downregulated pre-miRs in pre-senescent cells can 
delay the appearance of the senescence. 
Finally, related to basic and biomedical aging research, of particular 
interest it will be to explore the possibility that some of these microRNAs 
may be used as markers of aging and of the onset of age-related diseases. 
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